SUPERNUS PHARMACEUTICALS INC (SUPN) Stock Cash Flow
NASDAQ:SUPN - Nasdaq - US8684591089 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | 73.86M | 1.32M | 60.70M | 53.40M | 127.00M | |||
| Depreciation Amortization | 80.41M | 84.86M | 85.50M | 32.60M | 18.10M | |||
| Income Taxes - Deferred | -20.14M | -25.71M | -26.30M | -5.00M | 600.00K | |||
| Change In Working Capital | -2.05M | -9.14M | -22.10M | 3.60M | -36.50M | |||
| Interest Paid | 0.00 | 1.95M | 2.50M | 2.50M | 2.50M | |||
| Taxes Paid | 53.25M | 36.60M | 16.20M | 25.20M | 45.40M | |||
| Other non cash items | 39.86M | 59.76M | 19.00M | 42.50M | 29.30M | |||
| OPERATING CASH FLOW | 171.95M | 111.08M | 116.80M | 127.10M | 138.40M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -725.00K | -551.00K | -400.00K | -2.00M | -3.40M | |||
| Other Investing Activity | -189.14M | 269.28M | -216.30M | -79.90M | -31.30M | |||
| INVESTING CASH FLOW | -189.87M | 268.73M | -216.70M | -81.90M | -34.70M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 0.00 | -402.50M | 0.00 | -137.50M | -800.00K | |||
| Stock Issued/Repurchased | 14.91M | 6.61M | 12.40M | 7.10M | 4.40M | |||
| Other Financing Activity | -2.71M | -1.99M | -22.90M | N/A | 0.00 | |||
| FINANCING CASH FLOW | 12.19M | -397.88M | -10.50M | -130.40M | 3.60M | |||
| CHANGE IN CASH | -5.72M | -18.07M | -110.40M | -85.20M | 107.30M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | 171.95M | 111.08M | 116.80M | 127.10M | 138.40M | |||
| Capital Expenditure | -725.00K | -551.00K | -400.00K | -2.00M | -3.40M | |||
| FREE CASH FLOW | 171.23M | 110.53M | 116.40M | 125.10M | 135.00M | |||
All data in USD